{"id":"https://openalex.org/W2804621147","doi":null,"title":"Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.","display_name":"Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2804621147","mag":"2804621147"},"language":"en","primary_location":{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/4999dcaa-89de-4bc7-b01e-0d1184982913","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/4999dcaa-89de-4bc7-b01e-0d1184982913","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frizziero, M, Lamarca, A, Kordatou, Z, Barriuso, J, Nuttall, C, Mcnamara, M, Hubner, R, Mansoor, W, Manoharan, P & Valle, J 2018, 'Carboplatin-Etoposide Chemotherapy (CB-ET) for Patients Diagnosed with Advanced Extra-Pulmonary (EP) Poorly Differentiated (PD) Neuroendocrine Carcinoma (NEC): Findings from a European Neuroendocrine Tumor Society Centre of Excellence', 15th Annual ENETs conference, Barcelona, Spain, 7/03/18 - 9/03/18.","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026103439","display_name":"Melissa Frizziero","orcid":"https://orcid.org/0000-0001-5598-8771","observed_orcids":["https://orcid.org/0000-0001-5598-8771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Frizziero","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5598-8771","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087850177","display_name":"\u00c1ngela Lamarca","orcid":"https://orcid.org/0000-0001-9696-6122","observed_orcids":["https://orcid.org/0000-0001-9696-6122","https://orcid.org/0000-0002-2254-7985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c1ngela Lamarca","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0001-9696-6122","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021051331","display_name":"Zoe Kordatou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zoe Kordatou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060729173","display_name":"Jorge Barriuso","orcid":"https://orcid.org/0000-0002-5641-9105","observed_orcids":["https://orcid.org/0000-0002-5641-9105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Barriuso","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0002-5641-9105","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050591807","display_name":"Christina Nuttall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Nuttall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041768679","display_name":"Mairead Geraldine McNamara","orcid":"https://orcid.org/0000-0002-2272-3678","observed_orcids":["https://orcid.org/0000-0002-2272-3678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mair\u00e9ad G. McNamara","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0002-2272-3678","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075059160","display_name":"Richard A Hubner","orcid":"https://orcid.org/0000-0002-7081-8823","observed_orcids":["https://orcid.org/0000-0002-7081-8823"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Hubner","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0002-7081-8823","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077184881","display_name":"Was Mansoor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Was Mansoor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107880619","display_name":"Prakash Manoharan","orcid":"https://orcid.org/0000-0002-5155-2310","observed_orcids":["https://orcid.org/0000-0002-5155-2310"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prakash Manoharan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077826150","display_name":"Juan W. Valle","orcid":"https://orcid.org/0000-0002-1999-0863","observed_orcids":["https://orcid.org/0000-0002-1999-0863","https://orcid.org/0000-0002-7964-8402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan W. Valle","raw_affiliation_strings":["Division of Cancer Sciences (L5)"],"raw_orcid":"https://orcid.org/0000-0002-1999-0863","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6443,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.9002045,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/neuroendocrine-carcinoma","display_name":"neuroendocrine carcinoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/poorly-differentiated-neuroendocrine-carcinoma","display_name":"poorly differentiated neuroendocrine carcinoma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8809999823570251},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4230000078678131},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.7639999985694885},{"id":"https://openalex.org/keywords/real-world-efficacy-and-safety","display_name":"real-world efficacy and safety","score":0.5759999752044678},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.4659999907016754},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.5289999842643738},{"id":"https://openalex.org/keywords/recist-response","display_name":"RECIST response","score":0.4909999966621399},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8721349239349365},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7382045388221741},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6829509139060974},{"id":"https://openalex.org/C3020482125","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine carcinoma","level":3,"score":0.6825747489929199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6719368100166321},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5547359585762024},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.5056333541870117},{"id":"https://openalex.org/C2780341458","wikidata":"https://www.wikidata.org/wiki/Q18391873","display_name":"Neuroendocrine differentiation","level":4,"score":0.5019619464874268},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41631385684013367},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4149850010871887},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.366375207901001},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1661798059940338},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15743279457092285},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/4999dcaa-89de-4bc7-b01e-0d1184982913","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/4999dcaa-89de-4bc7-b01e-0d1184982913","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frizziero, M, Lamarca, A, Kordatou, Z, Barriuso, J, Nuttall, C, Mcnamara, M, Hubner, R, Mansoor, W, Manoharan, P & Valle, J 2018, 'Carboplatin-Etoposide Chemotherapy (CB-ET) for Patients Diagnosed with Advanced Extra-Pulmonary (EP) Poorly Differentiated (PD) Neuroendocrine Carcinoma (NEC): Findings from a European Neuroendocrine Tumor Society Centre of Excellence', 15th Annual ENETs conference, Barcelona, Spain, 7/03/18 - 9/03/18.","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:2804621147","doi":null,"is_oa":false,"landing_page_url":"http://christie.openrepository.com/christie/handle/10541/621019","pdf_url":null,"source":{"id":"https://openalex.org/S84102376","display_name":"Neuroendocrinology","issn_l":"0028-3835","issn":["0028-3835","1423-0194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Neuroendocrinology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2775677389","https://openalex.org/W2919861477","https://openalex.org/W2904735416","https://openalex.org/W2185069710","https://openalex.org/W2259544457","https://openalex.org/W2767800342","https://openalex.org/W3125953933","https://openalex.org/W2549950263","https://openalex.org/W3207331705","https://openalex.org/W4388033615"],"abstract_inverted_index":{"Introduction:":[0],"Carboplatin-Etoposide":[1],"is":[2,244],"a":[3,260],"first-line":[4],"option":[5],"for":[6,173,221],"patients":[7],"(pts)":[8],"with":[9,38,44,246],"advanced":[10,39],"EP-PD-NEC.":[11],"Data":[12],"from":[13],"randomised":[14],"trials":[15],"are":[16],"lacking":[17],"Aim(s):":[18],"The":[19],"aim":[20],"was":[21,144,160,177,187,225],"to":[22,231,251],"provide":[23],"real-life":[24,249],"activity/efficacy/safety":[25],"data":[26],"on":[27,234],"CB-ET":[28,45,116,135,243],"in":[29,189,191,199,217,248,254],"this":[30],"setting":[31],"Materials":[32],"and":[33,93,127,140,164,204,212,258],"methods:":[34],"Records":[35],"of":[36,112,115],"pts":[37,51,67],"EP-PD-NEC":[40],"(06/09-":[41],"04/17)":[42],"treated":[43],"were":[46,52,68,117,201,215],"retrospectively":[47],"reviewed":[48],"Results:":[49],"Seventythree":[50],"identified;":[53],"median":[54],"(med)":[55],"follow-up":[56],"8.9":[57],"months":[58],"(m);":[59],"med":[60,132,137,155],"age":[61],"70":[62],"yrs":[63],"(range":[64],"36-88).":[65],"Most":[66,96],"male":[69],"(71%),":[70],"ECOG":[71],"performance":[72],"status":[73],"0-1":[74],"(75%),":[75],"no/mild":[76],"comorbidities":[77],"(73%).":[78],"Primary":[79],"tumor":[80],"in:":[81],"foregut":[82],"29%,":[83],"hindgut":[84],"19%,":[85],"genitourinary":[86],"20.5%,":[87],"pancreas":[88],"7%,":[89],"biliary":[90],"tract":[91],"4%":[92],"unknown":[94],"20.5%.":[95],"had":[97],"stage":[98],"IV":[99,210],"disease":[100,211],"(86%;":[101],"59%":[102],"liver":[103,213,223],"metastases).":[104],"Median":[105],"Ki-67":[106],"80%":[107],"(95%CI":[108,162,166,179,239],"69-80%).":[109],"A":[110],"total":[111],"83":[113],"courses":[114],"administered;":[118],"69":[119],"(83%)":[120],"1st-line":[121],"(1L),":[122],"13":[123],"(16%)":[124],"2nd-line":[125],"(2L)":[126],"1":[128],"(1%)":[129],"3rd-line":[130],"(3L);":[131],"4":[133],"cycles/line;":[134],"dose-intensity":[136],"96%":[138],"(1L)":[139],"90%":[141],"(2L).":[142],"ET":[143],"administered":[145],"orally":[146],"(65%),":[147],"intravenously":[148],"(34%)":[149],"or":[150],"not-specified":[151],"(1%).":[152],"In":[153],"1L/2L":[154,200],"progression":[156],"free":[157],"survival":[158,172],"(PFS)":[159],"5.8m":[161],"4.8-7.1)":[163],"5.2m":[165],"2.3-11),":[167],"respectively":[168],"(p>0.05).":[169,208],"Med":[170],"overall":[171],"the":[174,218,226,255],"whole":[175],"population":[176],"9.33m":[178],"7.5-12.0).":[180],"Response":[181],"(RECIST":[182],"v1.1;":[183],"71":[184],"evaluable":[185],"pts)":[186],"achieved":[188],"43%/30%":[190],"1L/2L,":[192],"respectively.":[193],"Commonest":[194],"grade":[195],"3-4":[196],"adverse":[197],"events":[198],"myelotoxicity":[202],"(31%/46%)":[203],"venous":[205],"thromboembolism":[206],"(10%/15%)":[207],"Stage":[209],"metastases":[214,224],"significant":[216],"univariate":[219],"analysis":[220,236],"PFS;":[222],"only":[227],"independent":[228],"factor":[229],"related":[230],"worse":[232],"PFS":[233],"multivariable":[235],"(HR":[237],"2.2":[238],"1.3-3.7);":[240],"p=0.002)":[241],"Conclusion:":[242],"associated":[245],"activity/efficacy":[247],"comparable":[250],"that":[252],"reported":[253],"current":[256],"literature":[257],"has":[259],"manageable":[261],"safety":[262],"profile.":[263]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-01T00:00:00"}